Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Long-Term Debt Issuances (2016 - 2019)

Historic Long-Term Debt Issuances for NovaBay Pharmaceuticals (NBY) over the last 6 years, with Q1 2019 value amounting to $2.0 million.

  • NovaBay Pharmaceuticals' Long-Term Debt Issuances changed N/A to $2.0 million in Q1 2019 from the same period last year, while for Dec 2019 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $500000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that NovaBay Pharmaceuticals reported Long-Term Debt Issuances of $2.0 million as of Q1 2019.
  • In the past 5 years, NovaBay Pharmaceuticals' Long-Term Debt Issuances registered a high of $2.0 million during Q1 2019, and its lowest value of $1.4 million during Q1 2016.